Kindly MD ( (NAKA) ) has released a notification of late filing.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Kindly MD, Inc., a Utah-based company, has filed a Form 12b-25 to notify the delay of its Form 10-Q (Quarter Report) for the period ending September 30, 2025. The primary reason for the delay is the complexity of accounting related to a recent merger with Nakamoto Holdings, Inc., which requires additional time to ensure compliance with U.S. GAAP and PCAOB standards. The company anticipates filing the delayed report within the 5-day extension period allowed by the SEC. Preliminary financial results indicate significant changes, including realized and unrealized losses on digital assets and a substantial loss on the acquisition of Nakamoto. These figures are subject to change upon completion of the quarter-end review. The company remains committed to compliance and transparency, as evidenced by the notification signed by CEO David Bailey.
The most recent analyst rating on (NAKA) stock is a Sell with a $0.50 price target. To see the full list of analyst forecasts on Kindly MD stock, see the NAKA Stock Forecast page.
Spark’s Take on NAKA Stock
According to Spark, TipRanks’ AI Analyst, NAKA is a Underperform.
The overall stock score of 38 reflects significant financial and technical challenges. The company’s financial performance is weak, with declining revenues and profitability issues. Technical analysis indicates bearish momentum, and valuation metrics are unattractive due to negative earnings. These factors collectively contribute to a low stock score.
To see Spark’s full report on NAKA stock, click here.
More about Kindly MD
Average Trading Volume: 23,416,955
Technical Sentiment Signal: Sell
For detailed information about NAKA stock, go to TipRanks’ Stock Analysis page.